CBT for Insomnia: Past, Present, and Future Directions
|
|
- Warren Wilkerson
- 5 years ago
- Views:
Transcription
1 CBT for Insomnia: Past, Present, and Future Directions J. Todd Arnedt, Ph.D. Associate Professor of Psychiatry and Neurology Director, Behavioral Sleep Medicine Program Acting Director, Sleep and Circadian Research Laboratory University of Michigan Medical School
2 X Conflict of Interest Disclosures for Speakers 1. I do not have any relationships with any entities producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients, OR 2. I have the following relationships with entities producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients. Type of Potential Conflict Details of Potential Conflict Grant/Research Support Consultant Speakers Bureaus Financial support Other 3. The material presented in this lecture has no relationship with any of these potential conflicts, OR 4. This talk presents material that is related to one or more of these potential conflicts, and the following objective references are provided as support for this lecture:
3 Learning Objectives 1. Understand rationale, indications, and current best practices for CBT for insomnia. 2. Learn research evidence supporting CBT for insomnia as a first-line treatment 3. Learn about recent research that may impact future clinical care: How? What? To Whom?
4 Treatment options for insomnia Prescription medications: o Benzodiazepine receptor agonists (BzRAs): zolpidem (Ambien)*, zolpidem tartrate (Intermezzo)*, eszopiclone (Lunesta)*, zaleplon (Sonata)* o Antidepressants: doxepin (Silenor)*, trazodone (Desyrel), mirtazepine (Remeron) o Anticonvulsants: gabapentin (Neurontin) o Antipsychotics: quetiapine (Seroquel) o Melatonin receptor agonists (MelRAs): ramelteon (Rozerem)* Over-the-counter (non-prescription) agents: o Antihistamines: diphenhyramine (Sominex), doxylamine (Unisom) o Herbal remedies: melatonin, chamomile, valerian o Alcohol Non-medication treatments: o Cognitive Behavioral Treatment for Insomnia o Chronotherapeutics *FDA-approved for insomnia
5 CBT is a First-Line Treatment for Insomnia CBT and benzodiazepine receptor agonists have been shown to be beneficial in the acute management of chronic insomnia (NIH Consensus and State of the Science Statement, 2005) 1 CBT-based treatment packages for chronic insomnia including sleep restriction and stimulus control are effective and therefore should be offered to patients as a first-line treatment (British Association for Psychopharmacology Consensus Statement, 2010) 2 1 J Clin Sleep Med 2005;1(4):412-21; 2 Wilson SJ. J Psychopharmacol 2010;24:
6 General Treatment Considerations: CBT for Insomnia Advantages Demonstrated efficacy Good durability of treatment gains Minimal side effects Increases patient selfefficacy Disadvantages Delayed gains Greater patient burden Close follow-up needed
7 INSOMNIA INTENSITY Model of Acute and Chronic Insomnia THRESHOLD 40 PERPETUATING FACTORS 20 PRECIPITATING FACTORS 0 PRE-MORBID ACUTE INSOMNIA EARLY INSOMNIA CHRONIC INSOMNIA PREDISPOSING FACTORS Adapted from Spielman A. Psychiatr Clin North Am 1987; 10:
8 CBT Indications/Contraindications Indications: o o o Chronic insomnia symptoms ( 3 x/wk for 3 months) Poor sleep practices and/or excessive sleep focus/worry Medication tolerance, adverse side effects, or contraindication o Patient preference Contraindications: o o o o o Short-term insomnia Symptoms of circadian rhythm sleep wake disorder Certain medical/psychiatric conditions (e.g., seizure disorder, bipolar disorder) Unstable comorbid condition (e.g., depression, chronic pain) Patient preference
9 Cognitive Behavioral Therapy (CBT) for Insomnia: Treatment Components BEHAVIORAL Sleep Restriction Stimulus Control Relaxation TREATMENT TARGETS Excessive time in bed Irregular sleep schedules Sleep incompatible activities Hyperarousal Adapted from Morin CM. COGNITIVE Beliefs/Attitudes TREATMENT TARGETS Unrealistic sleep expectations Misconceptions about sleep Sleep anticipatory anxiety Poor cognitive coping skills EDUCATIONAL Sleep Hygiene TREATMENT TARGETS Inadequate sleep hygiene
10 Stimulus Control Relaxation Specific Therapy CBT, with or without relaxation Multicomponent therapy (without cognitive therapy) Sleep Restriction Paradoxical Intention Biofeedback Sleep Hygiene Cognitive Therapy Existing Practice Parameters Morgenthaler T. Sleep 2006;29(11): Level of Evidence STANDARD STANDARD STANDARD GUIDELINE GUIDELINE GUIDELINE GUIDELINE INSUFFICIENT EVIDENCE INSUFFICIENT EVIDENCE Standard: High degree of clinical certainty Guideline: Moderate degree of clinical certainty Option: Uncertain clinical use
11 University of Michigan CBT Treatment Session Protocol Core Content 0 Treatment Overview Sleep Diary Orientation 1 Sleep Restriction Therapy Stimulus Control Therapy 2 Sleep Hygiene Education 3 Cognitive Therapy 1 4 Cognitive Therapy 2 5 Adjunctive Strategies (e.g., Relaxation) 6 Sleep Maintenance Relapse Prevention
12 Clinical Case HPI: Med hx: 61 yo man with 33-year h/o nightly sleep onset and maintenance insomnia (TST 2-3 hrs/night); daytime fatigue and anxiety; worries about sleep; good sleep hygiene. high cholesterol, generalized chronic pain Psych hx: Sleep hx: Panic disorder without agoraphobia, MDD currently in treatment and improving No other sleep disorders (negative PSG); previous sleep hygiene intervention yielded temporary symptom improvement Psychosocial hx: married, retired professor, consultant 1 week/month Meds: Paxil 15 mg, Xanax.5 mg prn, previous trials of Serax, Valium, Doxepin, Chloral hydrate, Benadryl, Trazodone, Ambien, Lunesta
13 Clinical Case: Session 1 Summary Sleep Latency (SL; min) 60.0 Frequency of Night Awakenings (FNA) 3.4 Wake After Sleep Onset (WASO; min) Early Morning Awakenings (EMA; min) 12.0 Total Sleep Time (hrs) 3.8 Sleep Efficiency (SE; %) 53.0 BL 1. SRT: TIB = 5.5 hours (12:00 am - 5:30 am) 2. Follow stimulus control procedures 3. Wind-down minutes before bedtime
14 Clinical Case: Session 2 Summary BL Wk1 SL (min) FNA WASO (min) EMA (min) TST (hrs) SE (%) SRT: TIB = 5.8 hours (11:40 pm - 5:30 am) 2. Continue stimulus control and wind-down 3. S/H: regularize snack, enhance bedroom comfort and temp 4. Introduced cognitive therapy for insomnia
15 Clinical Case: Session 7 Summary BL Wk1 Wk3 Wk5 Wk7 SL (min) FNA WASO (min) EMA (min) TST (hrs) SE (%) Continue extending sleep schedule if desired 2. Follow sleep maintenance procedures 3. Consider discontinuing Xanax entirely
16 Efficacy of CBT: Meta-Analyses Sleep Parameter Morin et al. (1994) Murtagh & Greenwood (1995) Smith et al. (2002) Sleep Latency Wake after Sleep Onset Number of Awakenings Total Sleep Time Sleep Quality Morin CM et al., Am J Psychiatry 1994;151: Murtagh DRR & Greenwood KM, JCCP 1995; 63: Smith MT et al., Am J Psychiatry 2002;159: th percentile 70 th percentile
17 % patients achieving remission Efficacy of CBT comorbid with mental disorders 30 patients with co-morbid insomnia and MDD received 12 weeks of escitalopram with 7 weeks of individual CBT-I or behavioral placebo p=0.05 CBT-I Placebo 62 p= Insomnia MDD Manber R. Sleep 2008;31(4):
18 Total Wake Time (min) CBT vs. Pharmacotherapy: Direct comparison 46 older adults with chronic insomnia randomized to 6 weeks of CBT, zopiclone, or placebo * * * Pre-tx Post-tx (6 wks) 6 mos f/u 50 *p< Placebo CBT Zopiclone 7.5 mg Sivertsen B. JAMA 2006;295:
19 % Change from Pre-treatment Long-term Efficacy of CBT Month Follow-Up Wake after sleep onset Total sleep time Sleep efficiency CBT Medication (temazepam) Morin CM. JAMA 1999;281:991-9.
20 Clinical Case: 8-week Follow-up BL Wk1 Wk3 Wk5 Wk7 Wk15 SL (min) FNA WASO (min) EMA (min) TST (hrs) SE (%)
21 Future of CBT for Insomnia
22 Stepped Care Model of Insomnia Adapted from Espie CA. Sleep 2009; 32(12):
23 Self-Help CBT: Meta-Analysis OR=2.61 Cohen s d SE = 0.80; Cohen s d SL =0.66; Cohen s d WASO=0.55 Ho FY-Y. Sleep Med Rev 2015;19:17-28.
24 ISI Score Sleep Efficiency (%) Format: Internet-Based CBT 20 Baseline Post-tx 6-mo f/u 100 Baseline Post-tx 8-wk f/u N=45 SHUTi WLC N=164 ecbt IRT Ritterband LM. Arch Gen Psychiatry 2009;66(7):692-8; Espie CA. Sleep 2012;35(6):
25 Scale Score National Dissemination of CBT for Insomnia in Veterans 30 Baseline Post-tx 102 VA Mental Health Providers 21 Social Workers 74 Psychologists d=2.2 N=182 d=0.6 2 Psychiatrists 5 Nurses ISI BDI-II *60% had decrease 8 points on ISI Karlin BE. J Consult Clin Psychol 2013;81(5):912-7.
26 % participants Brief Behavioral Treatment in Older Adults with Insomnia 79 older adults with chronic insomnia received 2 sessions of Brief Behavioral Treatment of Insomnia (BBTI) or Information Control (IC) X 2 =16.9, p<.001 BBTI IC Remission Response Partial Response No Response Buysse DJ. Arch Intern Med 2011;171(10):
27 % Responders (ISI change 8 points) Dismantling CBT for Insomnia Treatment Components 188 adults with chronic insomnia received 8 weekly individual sessions of CBT, BT, or CT with 6-month follow-up OR=2.8 OR=2.8 OR=2.6 CBT BT CT OR= Post-treatment 6-mos f/u Harvey AG. J Consult Clin Psychol 2014;82(4):
28 % patients achieving remission Combination Therapy: Maintenance treatment 160 chronic insomnia patients received 6 weeks of acute treatment and then no vs. monthly (CBT-I group) or prn vs. taper (CBT/zolpidem) CBT - none CBT - monthly Comb - prn Comb - taper Overall remission rates after follow-up: 43% (CBT-I alone) vs. 56% (CBT-I + zolpidem) mo f/u Morin CM. JAMA 2009;301(19): mo f/u
29 % participants 40 adults with acute insomnia (DSM-V insomnia disorder of <3 mos duration) received minute session of CBT with 4-week follow-up Indications: Acute Insomnia X 2 =8.6, p<.003 CBT X 2 =7.6, p<.01 Wait-list Response (ISI <10) Remission (ISI <8) Ellis AG. Sleep 2015;38(6):971-8.
30 Indications: Side Effects 16 insomnia patients received 4 weeks of sleep restriction therapy (SRT) and were evaluated with performance testing (PVT) and polysomnography PVT Lapses Polysomnography Kyle SD. Sleep 2014;37(2):
31 Indications: At-Risk Insomnia Subgroups 1395 adults assessed at baseline for insomnia and objective sleep duration (with PSG) and followed up after 7.5 years for incident hypertension. Fernandez-Mendoza J. Hypertension 2012;60(4):
32 Summary and Conclusions CBT is a first-line treatment for chronic insomnia with a strong evidence base Emerging research findings will present opportunities and challenges to the clinical practice of CBT for insomnia Future research needed on utility of insomnia risk stratification, predictors of treatment response, efficacy of CBT for insomnia phenotypes, and benefits of increased CBT personalization
Insomnia treatment in primary care
Insomnia treatment in primary care Daniel J. Buysse, MD UPMC Professor of Sleep Medicine Professor of Psychiatry and Clinical and Translational Science University of Pittsburgh School of Medicine buyssedj@upmc.edu
More informationInsomnia Treatment in Brief
Insomnia Treatment in Brief Project ECHO May 7, 2015 Jonathan Emens, M.D. Associate Professor, Departments of Psychiatry and Internal Medicine Oregon Health & Science University Staff Physician and Sleep
More informationCPT David Shaha, MC US Army
CPT David Shaha, MC US Army None Thoughts and comments are my own and do not represent the official policy of the Department of the Army, Department of Defense, or United States Government. Clinical Case
More informationCognitive Behavioral Therapy for Insomnia. Melanie K. Leggett, PhD, CBSM Duke University Medical Center
Cognitive Behavioral Therapy for Insomnia Melanie K. Leggett, PhD, CBSM Duke University Medical Center Disclosures I have no relevant financial relationship with the manufacturers of any commercial products
More informationCognitive-Behavioral Therapy for Insomnia
Wisconsin Department of Health Services Wisconsin Public Psychiatry Network Teleconference (WPPNT) This teleconference is brought to you by the Wisconsin Department of Health Services (DHS) Bureau of Prevention,
More informationQuestion #1. Disclosures. CAPA 2015 Annual Conference. All of the following occur as we get older EXCEPT: Evaluating Patients with Insomnia
Evaluating Patients with Roger D. Seheult, M.D. Pulmonary Critical Care Physician - Beaver Medical Group, Redlands California Assistant Clinical Professor of Medicine - Loma Linda University School of
More informationInsomnia Agents (Sherwood Employer Group)
Insomnia Agents (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf Link to
More informationLearning Objectives. Management of Insomnia. Impact of Chronic Insomnia. Insomnia: Definitions. Measurement of Goals. Goals of Therapy 9/29/2017
Learning Objectives Characterize insomnia and its negative effects Management of Insomnia Discuss the goals of treatment Summarize guidelines of management of insomnia including non-pharmacologic and pharmacologic
More informationHow to Manage Insomnia with and without medications
How to Manage Insomnia with and without medications Tatyana Gurvich, Pharm.D. USC School of Pharmacy UC Irvine SeniorHealth Center Insomnia: How common is it? 26-50% of adult population complain of insomnia
More informationInsomnia % of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences)
10-15% of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences) 30 40% of adults complain of insomnia symptoms only 95% experience insomnia at some time in their
More informationInsomnia: Updates in Medical Management. Michael Newnam M.D.
Insomnia: Updates in Medical Management Michael Newnam M.D. Sleep Neurobiology Delicate balance of excitatory and inhibitory neurotransmitters that control the switch between wakefulness and sleep Circadian
More informationPharmacological Help for a Good Night s s Sleep. Thomas Owens, MD
Pharmacological Help for a Good Night s s Sleep Thomas Owens, MD Objectives 1. Define insomnia and characterize the symptoms and array of causes. 2. Describe traditional and new pharmacologic approaches
More informationObjectives. Disclosure. APNA 26th Annual Conference Session 2017: November 8, Kurtz 1. The speaker has no conflicts of interest to disclose
Christine Kurtz, DNP, PMHCNS BC Valparaiso University Disclosure The speaker has no conflicts of interest to disclose Objectives The learner will Describe the rationale for and five therapies of CBT I
More informationInsomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier
Insomnia Teofilo Lee-Chiong MD Professor of Medicine National Jewish Health University of Colorado Denver School of Medicine Learning Objectives Learn about the causes of transient and chronic Learn how
More informationAvailable Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Sleeping Disorders P&T DATE: 12/14/2016 THERAPEUTIC CLASS Psychiatric Disorders REVIEW HISTORY: 2/16, 5/15, 2/12 LOB AFFECTED
More informationSleep Science: better sleep for you and your patients CHUNBAI ZHANG, MD MPH UW MEDICINE VALLEY MEDICAL CENTER
Sleep Science: better sleep for you and your patients CHUNBAI ZHANG, MD MPH UW MEDICINE VALLEY MEDICAL CENTER Disclosure: Financial - none Non-Financial - none Selected Topics Sleep epidemiology Sleep
More informationINSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4
INSOMNIA IN THE GERIATRIC POPULATION Shannon Bush, MS4 CHANGES IN SLEEP ARCHITECTURE 2 Reduction in slow wave sleep (stage 3 and 4) Increase in lighter stages of sleep (stage 1 and 2) Decrease in REM sleep
More informationDr Alex Bartle. Sleep Well Clinic
Dr Alex Bartle Sleep Well Clinic Overview of Sleep Disorders Sleep: Why bother. Effect of Poor Quality or reduced Quantity of Sleep Common Sleep Disorders Management of Insomnia Medication vs CBTi Conclusion
More informationPsychopharmacology of Sleep Disorders
Psychopharmacology of Sleep Disorders John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor of Psychiatry
More informationDefinitions. Prevalence. Chronic Insomnia DSM-5 INSOMNIA. Insomnia Is a Distinct Disorder That Should Be Treated ~10% 3 nights/wk 3 months
Chronic Definitions Alon Y. Avidan, M.D., M.P.H UCLA Sleep Disorders Center Is a Distinct Disorder That Should Be Treated NIH (1983) 1 NIH (2005) 2 is a symptom, is a disorder not a disorder DSM-5 INSOMNIA
More informationInsomnia. Dr Terri Henderson MBChB FCPsych
Insomnia Dr Terri Henderson MBChB FCPsych Plan Basics of insomnia Pharmacology Medication CBT Details of insomnia Unsatisfactory sleep that impairs daytime well-being Starts with specific problem or change
More informationInsomnia Disorder A Journey to the Land of No Nod
Insomnia Disorder A Journey to the Land of No Nod JACQUELINE D. KLOSS, PH.D. P S Y C H O L O G I S T B R Y N M A W R P S Y C H O L O G I C A L A S S O C I A T E S B E H A V I O R A L S L E E P M E D I
More informationModern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures If Only I Could Sleep Like I Did Before Sleep Case 52 yr. old WF with >4 yr. of poor sleep
More informationTreating Insomnia in Primary Care. Judith R. Davidson Ph.D., C. Psych. Kingston Family Health Team
Treating Insomnia in Primary Care Judith R. Davidson Ph.D., C. Psych. Kingston Family Health Team jdavidson@kfhn.net Disclosure statement Nothing to disclose A ruffled mind makes a restless pillow. ~ Charlotte
More informationModern Management of Sleep Disorders
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance
More informationManaging Insomnia Disorder A Review of the Research for Adults
Managing Insomnia Disorder A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional said you have insomnia disorder (said
More informationDSM-5 INSOMNIA. Maintaining. Maintaining Sleep. Difficulty Falling Asleep: Difficulty. Early AM awakenings: (> 30 minutes before desired wake time)
DSM-5 INSOMNIA 3 nights/wk 3 months Difficulty Falling Asleep: > 30 minutes Difficulty Maintaining Sleep Next Day Consequences Early AM awakenings: (> 30 minutes before desired wake time) Initiation Trouble
More informationIntroduction. v Insomnia is very prevalent in acute (30-50%) and chronic forms (10-15%). v Insomnia is often ignored as a symptom of other disorders.
Introduction v Insomnia is very prevalent in acute (30-50%) and chronic forms (10-15%). v Insomnia is often ignored as a symptom of other disorders. v Insomnia is a risk factor for psychiatric and medical
More informationInsomnia treatment. Sleep hygiene education sleep hygiene teaches good sleeping habits. This includes:
Insomnia treatment INSOMNIA OVERVIEW insomnia is defined as difficulty falling asleep, difficulty staying asleep, or waking up early in the morning and not being able to return to sleep. In general, people
More informationSleeping your way to better mental health
Sleeping your way to better mental health Liverpool PWP Master Class 28 th January 2015 Dr Sophie Bostock sophie@sleepio.com Sleep Matters What we ll cover today.. 1. Sleep and mental health are intimately
More informationAddressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling
Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Educational Objectives: At the completion of this knowledge-based activity, participants will be able to:
More informationGuideline for Adult Insomnia
Guideline for Adult Insomnia Exclusions This guideline does not apply to: Children under the age of 18 Pregnant and lactating women Geriatric patients: While the general principles of the diagnosis and
More informationInsomnia and Aging: Epidemiology and Treatment
Insomnia and Aging: Epidemiology and Treatment Charles M. Morin, PhD Professor of Psychology Canada Research Chair (Behavioral Sleep Medicine) Université Laval, Québec, Canada Outline of Presentation Epidemiology
More informationModern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance
More informationWHEN SHOULD I USE SLEEP AIDS IN MY PATIENTS WITH SLEEP DISORDERS... (AND WHEN SHOULD I NOT?)
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences WHEN SHOULD I USE SLEEP AIDS IN MY PATIENTS WITH SLEEP DISORDERS... (AND WHEN SHOULD I NOT?) CATHERINE MCCALL, MD
More informationChronic Insomnia: DSM - V. Insomnia DSM - V. Patient Symptoms. Insomnia: Assessment and Overview of Management. Insomnia Management in the Digital Age
Insomnia Management in the Digital Age Dr Anup Desai Sleep & Respiratory Medicine MBBS (syd), PhD (syd), FRACP Senior Staff Specialist, POW Hospital Medical Director, Sydney Sleep Centre Senior Lecturer,
More informationDr June Brown Senior Lecturer in Clinical Psychology Institute of Psychiatry
Dr June Brown Senior Lecturer in Clinical Psychology Institute of Psychiatry Background to insomnia Design of study Methods Results Conclusions Where next? Insomnia is the most common mental health symptom
More informationTITLE: Cognitive Behavioural Therapy for Insomnia in Adults: A Review of the Clinical Effectiveness
TITLE: Cognitive Behavioural Therapy for Insomnia in Adults: A Review of the Clinical Effectiveness DATE: 11 May 2010 CONTEXT AND POLICY ISSUES: Insomnia refers to difficulty initiating and/or maintaining
More informationPRACTICAL MANAGEMENT OF INSOMNIA IN THE OFFICE
PRACTICAL MANAGEMENT OF INSOMNIA IN THE OFFICE NORAH VINCENT, PHD., C. PSYCH. PSYCHOLOGIST, WINNIPEG REGIONAL HEALTH AUTHORITY PROFESSOR, DEPARTMENT OF CLINICAL HEALTH PSYCHOLOGY, UNIVERSITY OF MANITOBA
More informationEffective Health Care Program
Comparative Effectiveness Review Number 159 Effective Health Care Program Management of Insomnia Disorder Executive Summary Introduction Sleep problems are common concerns for adults. 1 Compromised sleep
More informationSleep Disorders: Assessment and Therapeutic Options
Sleep Disorders: Assessment and Therapeutic Options John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor
More informationSEDATIVE-HYPNOTIC AGENTS
SEDATIVE-HYPNOTIC AGENTS Documentation A. FDA approved indications 1. Insomnia 2. Sedation for an agitated patient in an inpatient setting Documentation B. Non-FDA approved, commonly used indications 1.
More informationEarl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles
Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles Sleep Disorders Restless Legs Syndrome (RLS) and Periodic Limb Movement Disorder (PLMD) Sleep
More informationInsomnia: habits, help, and hazards
Insomnia: habits, help, and hazards Balanced data about medications www.rxfacts.org Copyright 2010 by The Alosa Foundation www.rxfacts.org November 2010 2 www.rxfacts.org Author: Leslie Jackowski, B.Sc.,
More information6/3/2015. Insomnia An Integrative Approach. Objectives. Why An Integrative Approach? Integrative Model. Definition. Short-term Insomnia
Insomnia An Integrative Approach Jeffrey S. Jump, M.D. Medical Director CHI Memorial Integrative Medicine Associates Objectives Understand the importance of sleep to health Identify patients with insomnia
More informationGoals. Brief Behavioural Interventions for Insomnia. What is insomnia? RCPsych International Congress, London 2014
Brief Behavioural Interventions for Insomnia RCPsych International Congress, London 2014 Dr David O Regan PhD MRCPsych, ST5 Higher Trainee Insomnia Clinic, Royal London Hospital for Integrated Medicine
More informationDrug Class Review on Newer Drugs for Insomnia
Drug Class Review on Newer Drugs for Insomnia Final Report July 00 The Agency for Healthcare Research and Quality has not yet seen or approved this report The purpose of this report is to make available
More informationADULT PRIMARY INSOMNIA
Clinical Practice Guideline Adult Primary Insomnia: Diagnosis to Management 2007 Update This guideline was developed by a Clinical Practice Guidelines Working Group to assist physicians in the management
More informationOptimal Sleep Using NeurOptimal -Insomnia Studies
Optimal Sleep Using NeurOptimal -Insomnia Studies Edward B. O'Malley, PhD, FAASM Diplomate, American Board of Sleep Medicine Managing Director, Sleep HealthCare of CT Fairfield, CT eomalley@sleephelathcarect.com
More informationAmbien vs Rozerem There are people out there who have trouble falling asleep at night. Â Often, this would be considered as a disease that
22-10-2013 Ambien vs Rozerem There are people out there who have trouble falling asleep at night. Â Often, this would be considered as a disease that can be treated with Ambien vs Rozerem. Ambien:. Ramelteon
More informationINDEX. Group psychotherapy, described, 97 Group stimulus control, 29-47; see also Stimulus control (group setting)
Index Abdominal breathing, 70; see also Breathing; Relaxation therapy Activation, sleep drive/responsivity, 6-9 Age level; see also Elderly circadian rhythms and, 68-69 delayed sleep phase syndrome and,
More informationTreating sleep disorders
Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London sue.wilson@imperial.ac.uk Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with
More informationTRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE
TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE Gordon Ang, PharmD Central Texas Veterans Health Care System 1/5/2018 1 Abbreviations Abbreviation GERD MDD PTSD PSQI
More informationComorbid insomnia is a relatively new term within
n report n Current and New Thinking in the Management of Comorbid Insomnia David N. Neubauer, MD Abstract Insomnia occurs predominantly in conjunction with a medical or psychiatric illness. New thinking
More informationObjectives. Types of Sleep Problems in Developmental Disorders
Objectives Sleep Problems in the Child with Neurodevelopmental Disorders AACPDM September 11, 2014 BRK-3 Golda Milo-Manson MD, MHSc, FRCP(C) Holland Bloorview Kids Rehabilitation Hospital Toronto, Canada
More informationFaculty/Presenter Disclosure
A Little CBT I With My Tea Please: Cognitive Behavioural Therapy for insomnia (CBT I) and Its Use In the Treatment of Sleeplessness W. Jerome Alonso, MD Medical Director, Canadian Sleep Consultants Clinical
More informationDrug Review Rozerem (ramelteon)
Drug Review Rozerem (ramelteon) Introduction 1 Ramelteon is a melatonin receptor agonist with affinity for MT 1 and MT 2 and selectivity over the MT 3 receptor. The activity at the MT 1 and MT 2 receptors
More informationComparison of Insomnia Treatments
PL Detail-Document #280504 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER May 2012 Comparison of Insomnia
More informationSeminar. Chronic insomnia
Chronic insomnia Charles M Morin, Ruth Benca Insomnia is a prevalent complaint in clinical practice that can present independently or comorbidly with another medical or psychiatric disorder. In either
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Non-Benzodiazepine Insomnia Reference Number: CP.PMA_10.11.23 Effective Date: 07.16 Last Review Date: 04.18 Line of Business: Medicaid- Arizona (AHCS, CIC) Revision Log See Important Reminder
More information3/24/2016 DISCLOSURE STATEMENT PHARMACIST OBJECTIVES OVERVIEW TECHNICIAN OBJECTIVES PREVALENCE OF INSOMNIA THE WRONG SIDE OF THE BED: CHRONIC INSOMNIA
DISCLOSURE STATEMENT I do not have any actual or potential conflict of interest in relation to this presentation THE WRONG SIDE OF THE BED: CHRONIC INSOMNIA DANIELLE ROWAN, PHARMD, MBA PGY1 PHARMACY PRACTICE
More informationClinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Special Article Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults Sharon Schutte-Rodin, M.D. 1 ; Lauren Broch, Ph.D. 2 ; Daniel Buysse, M.D. 3 ; Cynthia Dorsey, Ph.D. 4
More informationInsomnia. Arturo Meade MD
Insomnia Arturo Meade MD Goals Definition Prevalence Pathophysiology The role of Orexin Orexin receptor blockers Consequences: Daily Functioning Insomnia: Consequences Decreased quality of life
More informationcontinuing education for pharmacists
continuing education for pharmacists General Insomnia Disorder in Adults and Treatment Guidelines Amanda R. Kriesen, R.Ph., PharmD Volume XXXV, No. 9 Dr. Amanda Kriesen has no relevant financial relationships
More informationBeyond Sleep Hygiene: Behavioral Approaches to Insomnia
Beyond Sleep Hygiene: Behavioral Approaches to Insomnia Rocky Garrison, PhD, CBSM Damon Michael Williams, RN, PMHNP-BC In House Counseling Laughing Heart LLC 10201 SE Main St. 12 SE 14 th Ave. Suite 10
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES. SEDATIVE HYPNOTIC AGENTS Generic Brand HICL GCN Exception/Other ZOLPIDEM
Generic Brand HICL GCN Exception/Other ZOLPIDEM AMBIEN 07842 GENERIC IS UNRESTRICTED TARTRATE AMBIEN CR EDLUAR INTERMEZZO ZOLPIMIST ESZOPICLONE LUNESTA 26791 GENERIC IS UNRESTRICTED RAMELTEON ROZEREM 33126
More informationSLEEP-WAKE DISORDERS: INSOMNIA. Prof. Paz Gía-Portilla
SLEEP-WAKE DISORDERS: INSOMNIA Prof. Paz Gía-Portilla SLEEP-WAKE DISORDERS AND ICD-10 Chapter V: Mental and Behavioural Disorders F51. Non-organic sleep disorders Chapter VI: Nervous System Illnesses G47.
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Non-Benzodiazepine Insomnia Medications Reference Number: CP.HNMC.265 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder
More informationInsomnia Pharmacotherapy A Practical Guide for Primary Care
Insomnia Pharmacotherapy A Practical Guide for Primary Care Offices in Jacksonville, Florida Fortis Spectrum is the educational partner for this session. Session 3: Insomnia Pharmacotherapy: A Practical
More informationSedative Hypnotics. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.60.11 Subject: Sedative Hypnotics Page: 1 of 7 Last Review Date: December 8, 2017 Sedative Hypnotics
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Non-Benzodiazepine Insomnia Medications Reference Number: CP.CPA.265 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at
More informationSedative Hypnotics. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.60.11 Subject: Sedative Hypnotics Page: 1 of 8 Last Review Date: September 15, 2016 Sedative Hypnotics
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationDrug Class Update: Sedatives
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationAnxiolytic and Hypnotic drugs
Anxiolytic and Hypnotic drugs Anxiolytic and Hypnotic drugs Anxiety is unpleasant state of tension and fear that seems to arise from unknown source. The symptoms of severe anxiety are similar to those
More informationANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN
UW PACC Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL
More informationRECOMMENDATIONS. TARGET POPULATION Adults. EXCLUSIONS Children under the age of 18 years Overnight/rotating shift workers
ASSESSMENT TO MANAGEMENT OF ADULT INSOMNIA Clinical Practice Guideline December 2015 OBJECTIVE Clinicians in Alberta will know how to assess and diagnose insomnia; when insomnia can be effectively treated
More informationAGING CHANGES IN SLEEP
OBJECTIVES: Understand the common age-related changes in sleep Discuss the evaluation of the older person with sleep complaints Identify sleep apnea, PLMS, RLS, and REM sleep disorders and their treatments
More informationThe Reasons for Insomnia and the Ways to Fight It
The Reasons for Insomnia and the Ways to Fight It Insomnia is a relatively common sleep disorder, which is indicated by insufficient duration or unsatisfactory quality of sleep over an extended period.
More informationKU LEUVEN. Liesbet Van Houdenhove Clinical Psychologist Student Health Center KU Leuven
SLEEPLESS @ KU LEUVEN Liesbet Van Houdenhove Clinical Psychologist Student Health Center KU Leuven Background Impaired sleep is a frequent and important health problem in college students Prevalence rates
More informationWeekly Sleep Diary. Name Instructions: Keep this at your bedside and complete each morning upon awakening. Day of the week. Total Sleep Time (TST)
Weekly Sleep Diary Name Instructions: Keep this at your bedside and complete each morning upon awakening. Day of the week Calendar date Yesterday, I napped for: (add total naps, eg., 15 mins, ½, 1, 2 hrs,
More informationRevolutionizing Cost Management... One Person at a Time.
Cypress Care, a leader in the workers compensation industry has expanded into the auto and Medicare Set-Aside markets by applying best practices and expertise - focused toward a single goal: Help our clients
More informationTherapeutic brief 18
Therapeutic brief 18 Insomnia Management: Effective approaches for a common problem A large amount of research supports the benefits of nondrug therapies for insomnia. 1-4 Non-drug therapies based on behavioural
More informationOBJECTIVES. The psychiatric, medical, and neurologic causes of sleep problems. Office-based and objective methods of evaluating sleep
SLEEP ISSUES 1 OBJECTIVES 2 Know and understand: Age-related changes in sleep The psychiatric, medical, and neurologic causes of sleep problems Office-based and objective methods of evaluating sleep Appropriate
More informationFor: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013
For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 This power point is only a guideline for recommendations in the treatment of psychiatric disorders. This is not comprehensive. Please
More information일차진료에서불면증치료 김종우. Primary Insomnia : DSM-IV criteria 경희대학교의과대학정신과학교실 MEMO. Diagnostic Criteria for Insomnia (ICSD-2) 개원의와함께하는임상강좌
개원의와함께하는임상강좌 2011 일차진료에서불면증치료 경희대학교의과대학정신과학교실 김종우 Diagnostic Criteria for Insomnia (ICSD-2) International Classification of Sleep Disorders, 2nd Edition (ICSD-2) Primary Insomnia : DSM-IV criteria A. The
More informationOutline. Disclosure. Sleep and the Elderly 1,2. Background
Geriatric Grand Rounds Tuesday, March 31, 29 12: noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this
More information6/10/2016. What is Insomnia? Why Treat Insomnia? What is Insomnia? Why Treat Insomnia? BEHAVIORAL SLEEP MEDICINE: MANAGEMENT OF INSOMNIA
What is Insomnia? BEHAVIORAL SLEEP MEDICINE: MANAGEMENT OF INSOMNIA Charles Schmittdiel, Ph.D., CBSM UT Erlanger Behavioral Health Acute Insomnia = Less than 3 months Usually happens after some type of
More informationMMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA
MMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA Page 1 of 11 Table of Contents Why we need this Guideline... 3 What the Policy is trying to do... 3 Which stakeholders have been
More informationSeptember 15, 2017 Pierre, SD End the Insomnia Struggle: An Individualized Approach to Treating Insomnia Using CBT-I and ACT
September 15, 2017 Pierre, SD End the Insomnia Struggle: An Individualized Approach to Treating Insomnia Using CBT-I and ACT Alisha L. Brosse, Ph.D. Boulder Center for Cognitive & Behavioral Therapies,
More informationInsomnia Pearls in the Geriatric Population
Insomnia Pearls in the Geriatric Population September 9, 2016 Stephanie Loegering, PharmD, CGP Clinical Pharmacist VA Medical Center Thank You MPhA Wi-fi Information: NETWORK: EC-CTR PASSWORD: westgate252
More informationObjectives. Sleep Problems in the Child with Physical Disabilities AACPDM September 14, Types of Sleep Problems
Sleep Problems in the Child with Physical Disabilities AACPDM September 14, 2017 Golda Milo-Manson MD, MHSc, FRCP(C) Holland Bloorview Kids Rehabilitation Hospital Toronto, Canada Objectives Current evidence
More informationInsomnia CLINICAL CROSSROADS CLINICIAN S CORNER
CONFERENCES WITH PATIENTS AND DOCTORS CLINICIAN S CORNER Insomnia Daniel J. Buysse, MD, Discussant DR SHIP: Ms J is a 51-year-old woman with insomnia, which began at age 35 years when her infant daughter
More informationWHEN COUNTING SHEEP FAILS: ADMINISTERING SINGLE-SESSION COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA IN A GROUP PSYCHOEDUCATIONAL FORMAT
WHEN COUNTING SHEEP FAILS: ADMINISTERING SINGLE-SESSION COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA IN A GROUP PSYCHOEDUCATIONAL FORMAT Kristin E. Eisenhauer, PhD. Trinity University San Antonio, Texas I
More information48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014
48 th Annual Meeting Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Published in 2013 Most published treatment guidelines
More informationAddressing Pharmacologic Issues in. DSM-5 Sleep-Wake. Insomnia. Disorders. DSM-5 Insomnia Disorder. Insomnia. Disorder
Addressing Pharmacologic Issues in David N. Neubauer, MD Associate Professor of Psychiatry and Behavioral Sciences Johns Hopkins School of Medicine Baltimore, Maryland Restless Legs Syndrome Substance/
More informationPRACTICAL APPROACH TO INSOMNIA in PRIMARY CARE. Karen Carlson, MD Massachusetts General Hospital Harvard Medical School
PRACTICAL APPROACH TO INSOMNIA in PRIMARY CARE Karen Carlson, MD Massachusetts General Hospital Harvard Medical School LEARNING OBJECTIVES To understand basic sleep physiology To know the evidence for
More informationInsomnia. St. Joseph s Annual Family Practice Refresher March 1, Robert J. Ostrander, M.D
St. Joseph s Annual Family Practice Refresher March 1, 2018 Robert J. Ostrander, M.D If in bed I say, When shall I arise? then the night drags on; I am filled with restlessness until the dawn. Job 7:4
More information11. Psychopharmacological Intervention
11. Psychopharmacological Intervention 11.1 Goals of Psychopharmacology The goal of psychopharmacology is to ensure that patients with more severe forms of depression and those who fail to benefit adequately
More informationEvidence Summary References Guideline Development Process and Team... 20
Insomnia Guideline Guideline Summary... 2 Background... 2 Assessment and Diagnosis... 3 Monitoring... 4 Treatment Foundations Normal sleep pattern changes in the elderly... 5 Step-wise approach to insomnia
More information